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Abstract
Most genome-wide association (GWA) studies have focused on populations of European ancestry with limited assessment
of the influence of the sequence variants on populations of other ethnicities. To determine whether markers that we have
recently shown to associate with Bone Mineral Density (BMD) in Europeans also associate with BMD in East-Asians we
analysed 50 markers from 23 genomic loci in samples from Korea (n= 1,397) and two Chinese Hong Kong sample sets
(n= 3,869 and n= 785). Through this effort we identified fourteen loci that associated with BMD in East-Asian samples using
a false discovery rate (FDR) of 0.05; 1p36 (ZBTB40, P= 4.361029), 1p31 (GPR177, P= 0.00012), 3p22 (CTNNB1, P= 0.00013),
4q22 (MEPE, P= 0.0026), 5q14 (MEF2C, P= 1.361025), 6q25 (ESR1, P= 0.0011), 7p14 (STARD3NL, P= 0.00025), 7q21 (FLJ42280,
P= 0.00017), 8q24 (TNFRSF11B, P= 3.461025), 11p15 (SOX6, P= 0.00033), 11q13 (LRP5, P= 0.0033), 13q14 (TNFSF11,
P= 7.561025), 16q24 (FOXL1, P= 0.0010) and 17q21 (SOST, P= 0.015). Our study marks an early effort towards the challenge
of cataloguing bone density variants shared by many ethnicities by testing BMD variants that have been established in
Europeans, in East-Asians.
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Introduction
Geographic ancestry is an important factor when considering the
genetic component of the risk of common complex diseases.
Variations in the underlying LD structure and in the frequency of
sequence variants are observed between populations of different
ancestry and are factors that influence the results of association
studies. An example of differences in risk assessment of a particular
sequence variant between ethinicities is the Atrial Fibrillation (AF)
locus on chromosome 4q25 where two variants confer risk of AF in
people of European descent. One of these two variants also confers
risk in Chinese individuals, where it is observed in higher frequency
and with a lower associated risk of AF, than in Europeans [1].
Another example of differences in both frequency and risk of a
variant is at a new locus for primary open-angle Glaucoma where a
reversed situation is observed, a lower frequency and higher risk in
Chinese population compared to Europeans [2]. Furthermore, a
recent ancestry-shift refinement effort at the ESR1 locus for breast
cancer demonstrated that despite apparent lack of association at this
locus in Europeans of a variant that was identified in East-Asians an
underlying risk variant common to both Europeans and East-Asians
could be identified [3].
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Bone mineral density (BMD) is the single best predictor of
fragility fractures [4,5] and is used as a reference standard for the
description of osteoporosis [6]. It is a highly familial quantitative
trait, with heritability estimates in the range of 0.6–0.8 [7,8], but is
also influenced by environmental and medical factors. Genome-
wide SNP association (GWA) studies have provided an important
opportunity to discover genes with sequence variants contributing
to bone density variations, and hence, osteoporosis. Through
GWA studies and meta-analysis of GWA studies we, and others,
have reported 23 genomic loci that associate with BMD at the
genome-wide significance (GWS) level in populations of European
ancestry [9–12]. Most GWA studies, including those of BMD [9–
15], have focused on populations of European ancestry.
Assessments of the effect of the identified sequence variants have
been limited in populations of other ethnicities. Recently, studies
in other populations than those of European descent have both
yielded new loci and information on their effect across ethnicities
[15–17], representing an early attempt to assess the effect of these
loci globally.
Here, we investigate if the BMD-related genetic variants we
previously reported in Europeans also associate with BMD in East-
Asians (Korean and two Chinese Hong Kong sample sets). We
tested markers from the 23 European GWS loci from our previous
scans and a meta-analysis [9,10,12].
Results and Discussion
Samples, marker selection for genotyping and analysis
The East-Asian samples used in this study comprised of Korean
postmenopausal women [18] (n=1,397), Chinese community-
dwelling elderly of both sexes from Hong Kong [19] (n=3,869),
hereafter called the Hong Kong-I samples, and Southern Chinese
females from Hong Kong with extreme BMD phenotypes (n=785)
[17], hereafter called the Hong Kong–II samples. Full description
of the studies is given in the Methods section and summary
characteristics of the study populations are shown in Table 1.
We tested markers from all 23 European GWS loci that we
identified in our previous scans and a meta-analysis [9,10,12]. We
analysed in the East-Asian samples a total of 50 SNPs (47 GWS
and 3 suggestive) from these 23 genomic loci. We directly
genotyped these markers in the Korean and the Hong Kong-I
samples and performed an in-silico lookup in the Hong Kong-II
extreme BMD samples which had previously been genotyped on
an Illumina SNP chip.
BMD at the hip (femoral-neck, FN or total-hip) and at the
lumbar spine (LS) was adjusted for age and body weight for each
sex and population separately. For each SNP, the allele that
associated with lowered BMD in the European populations was
tested separately for its association with BMD of the hip and for its
association with BMD of the spine. The results for the three East-
Asian sample sets were combined using inverse variance weighted
Z-scores.
The Simes procedure was used to control the FDR [20] in the
overall analysis rather than the conservative Bonferroni adjust-
ment, due to the large number of true positives that we expected to
find. We chose to use a FDR threshold of 0.05 which would have
corresponded to using a P value threshold of 0.001 based on the
Bonferroni adjustment, while the Simes procedure resulted in P
values below 0.021 and 0.025 being declared to associate with
spine and hip BMD, respectively. The Simes procedure was also
used to control the FDR when testing difference in effect between
the two ethnicities, resulting in a threshold of 0.012 and 0.008 for
spine and hip BMD, respectively.
Investigation of European bone density loci in
East-Asians
The previously reported GWS loci in European populations
that we tested were 1p36 (ZBTB40), 1p31 (GPR177), 2p21
(SPTBN1), 3p22 (CTNNB1), 4q22 (MEPE), 5q14 (MEF2C), 6p21
(MHC), 6q25 (ESR1), 7p14 (STARD3NL), 7q21 (FLJ42280), 8q24
(TNFRSF11B), 11p15 (SOX6), 11p11 (ARHGAP1) 11p13 (DCDC5),
11q13 (LRP5), 12q13 (SP7), 13q14 (TNFSF11), 14q32 (MARK3),
16q24 (FOXL1), 17q21 (SOST), 17q21 (HDAC5), 17q12 (CRHR1),
and 18q21 (TNFRSF11A) [9,10,12]. The full set of markers tested
is shown in Table S1.
Thirty markers from fourteen loci associated with BMD in East-
Asians in this study (FDR,0.05). Markers at ten loci associated
with both hip and spine BMD: 1p36, 1p31, 3p22, 4q22, 6q25,
7p14, 7q21, 8q24, 11q13 and 13q14. No other loci associated with
spine BMD while four additional loci associated with hip BMD:
5q14, 11p15, 16q24, 17q21. The results for the markers
associating with spine and hip BMD in East-Asians are shown in
Table 2 and Table 3, respectively, and the results for all the
tested markers are shown in Table S2 and Table S3.
Table 1. Summary characteristics of the study populations.
Hong Kong -I Honk Kong-II Korea
Men Women Women Women
high BMD low BMD
# 1882 1984 376 424 1396
Age (SD), year 72.41 (5.02) 72.59 (5.36) 46.6 (14.8) 51.1 (15.9) 59.06 (7.36)
Age-range, year 65–92 65–98 20–84 20–80 45–87
BMI (SD), kg/m2 23.45 (3.12) 23.92 (3.45) 24.58(4.11) 21.14(2.99) 23.4 (2.79)
Height (SD), cm 163.06 (5.76) 150.92 (5.31) 158 (6) 153 (7) 154.99 (5.31)
Weight (SD), kg 62.43 (9.37) 54.52 (8.5) 61.1 (9.9) 49.1 (6.7) 56.21 (7.15)
Hip BMD (SD) 0 (1) 0 (1) 1.15 (0.79) 21.36 (0.60) 0 (1)
Spine BMD (SD) 20.02 (0.99) 0 (1) 1.05 (0.78) 21.59 (0.53) 0 (1)
Mean age, height, weight, and BMI are shown for each study with standard deviations (SD) in parenthesis. Mean of adjusted hip BMD and spine BMD is shown (SD) and
the age-range of each study. Hong Kong-II: low BMD subjects are defined as an individual having BMD Z-score #21.28 at either lumbar spine (LS) or femoral neck (FN),
which is equivalent to the lowest 10% of the total population, while high BMD subjects are individuals with BMD Z-scores $ +1.0 at either of the two skeletal sites.
doi:10.1371/journal.pone.0013217.t001
BMD Loci in Europe/Asia
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Loci associated with both spine and hip BMD in
East-Asian samples
The 1p36 locus associated most significantly with BMD in this
study, typified by rs6426749 with a P=4.361029 for hip BMD
and 7.561026 for spine BMD. The estimated effect in the East-
Asians was very similar to that in the Europeans; rs6426749
associated with 0.11 SD lower hip BMD and 0.09 lower spine
BMD per copy of the G allele in the East-Asians compared to 0.08
and 0.11 SD in the Europeans, for hip BMD and spine BMD,
respectively [12]. All four markers tested at this locus are of very
similar frequencies in both ethnic groups (around 80% allelic
frequency), are highly correlated and are therefore assumed to
capture the same association signal.
Rs2566755 at the second locus on chromosome 1, 1p31, also
associated with both hip BMD and spine BMD in the East-Asian
samples with P=0.00014 for hip-BMD and P=0.00012 for spine-
BMD, and similar effect as in Europeans. The frequency of this
SNP is also comparable in both ethnic groups; the allele that
associates with lower BMD [A] is very frequent, between 77 and
79 percent.
We tested two markers at the 3p22 (CTNNB1) locus; rs87938
derived from the meta-analysis results and rs10490823, which we
had followed in our previous GWA study but had not reached
GWS [10]. The rs10490823 SNP associated with both hip BMD
(P=0.00013) and spine BMD (P=0.00015) in the East-Asians and
rs87938 associated with hip BMD (P=0.0095). Again, the effect
was very similar in the two ethnic groups; the rs10490823-G allele
associated with 0.07 SD lower hip BMD in East-Asians compared
to 0.06 SD in Europeans. The frequency of associated allele is
again high in both ethnicities, 46% in Europeans and 73% in the
East-Asians. These two markers, rs10490823 and rs87938, are
fully equivalent in the HapMap-CEU samples (r2 = 1) and
substantially correlated but not equivalent (r2 = 0.57, D’ = 1) in
the HapMap-JPT+CHB dataset. They are located 14 kb apart,
about 100 kb upstream of the CTNNB1 (catenin (cadherin-
associated protein), beta 1) gene.
The SNP rs1471403-C at 4q22 (MEPE) associated with both
hip BMD (P=0.0065) and spine BMD (P=0.0026) in the East-
Asians. Frequency of the rs1471403 C allele is comparable in
Europe and in the East-Asian samples; 65–70%, and the effect is
similar in both groups, the C allele associated with 0.05 SD lower
hip BMD and spine BMD.
The 6q25 (ESR1) is an example of a complex locus where most
markers differ in frequencies between Europeans and East-Asians;
only three of the ten markers that we tested are comparable in
frequency in the two ethnic groups. This locus also showed a
complex pattern of association in our previous study of the
European samples; the association signal could not be explained
by a single SNP and at least three SNPs were needed to fully
capture the association [9]. Five markers associated with hip BMD
Table 2. Association of European loci in East-Asian samples; spine BMD.
Korea (n =1,396)
HongKong-I
(n = 3,736)
Hong Kong-II
(n =785) (n =5,917)
Locus SNP Allele
Freq.
Europe
Freq.
Asia Effect P value Effect P value Effect P value
Effect
Asia
P value
Asia Phet I
2
1p36 rs7524102 A 0.830 0.794 20.09 0.041 20.08 0.0034 20.07 0.015 20.08 5.5e-05 0.96 0.0
rs6696981 G 0.864 0.803 20.08 0.065 20.08 0.0024 20.12 0.0011 20.09 7.0e-06 0.68 0.0
rs6426749 G 0.830 0.798 20.08 0.045 20.09 0.00070 20.08 0.0080 20.09 7.5e-06 0.96 0.0
rs7543680 G 0.772 0.763 20.07 0.075 20.06 0.0085 20.07 0.028 20.07 0.00036 0.99 0.0
1p31 rs2566755 A 0.790 0.773 20.14 0.0010 20.06 0.021 20.06 0.045 20.07 0.00012 0.23 32.8
3p22 rs10490823 G 0.460 0.742 20.07 0.055 20.05 0.035 20.12 0.00095 20.07 0.00015 0.32 12.0
4q22 rs1471403 C 0.660 0.665 20.05 0.11 20.05 0.016 20.04 0.085 20.05 0.0026 0.93 0.0
6q25 rs7751941 A 0.217 0.011 20.51 0.0075 20.17 0.055 20.22 0.050 20.23 0.0014 0.35 4.9
7p14 rs1524058 T 0.400 0.432 20.04 0.14 20.06 0.0028 20.05 0.029 20.06 0.00025 0.87 0.0
7q21 rs4729260 G 0.320 0.134 20.03 0.33 20.01 0.35 20.16 3.0e-05 20.07 0.0027 0.013 77.0
rs7781370 T 0.340 0.132 20.06 0.16 20.04 0.12 20.16 3.4e-05 20.08 0.00017 0.066 63.2
8q24 rs4355801 A 0.536 0.766 20.02 0.35 20.09 0.00080 20.08 0.030 20.07 0.00037 0.33 9.4
rs2062377 T 0.560 0.339 20.02 0.30 20.08 0.0022 20.06 0.033 20.06 0.00065 0.50 0.0
rs6469792 C 0.529 0.619 20.00 0.52 20.08 0.00055 20.10 0.0019 20.07 3.4e-05 0.21 35.5
rs6469804 A 0.518 0.805 20.01 0.40 20.08 0.0029 20.10 0.0080 20.07 0.00048 0.28 20.9
rs6993813 C 0.504 0.660 20.00 0.52 20.07 0.0043 20.09 0.0037 20.06 0.00032 0.30 17.1
11q13 rs599083 G 0.310 0.264 20.11 0.0029 20.04 0.070 20.04 0.10 20.06 0.0014 0.30 16.8
13q14 rs7992970 A 0.777 0.679 20.03 0.23 20.07 0.0029 -0.10 0.0026 20.07 7.5e-05 0.45 0.0
rs9594738 T 0.568 0.086 20.14 0.0095 20.07 0.055 20.09 0.060 20.09 0.0010 0.59 0.0
rs10507508 A 0.947 0.876 20.03 0.34 20.09 0.0023 20.13 0.0036 20.09 0.00011 0.42 0.0
rs9594751 T 0.265 0.065 20.14 0.021 20.12 0.0085 20.10 0.070 20.12 0.0003 0.92 0.0
The SNPs that associated with spine BMD in the East-Asian samples in this study are shown. The SNP alleles that associate with lower BMD in Europeans are shown and
their frequency in Europeans and East-Asians. The estimated effect on lumbar spine BMD is expressed as standard deviations below the mean. Single-sided P values are
shown for the individual sample sets separately (Korea, Hong Kong-I, Hong Kong-II) and the three samples sets combined. Heterogeneity P values (Phet) and estimates
(I2) are given.
doi:10.1371/journal.pone.0013217.t002
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and one markers with spine BMD in the East-Asians; the
rs7751941 (allele A, 1.1% freq.) in common to both skeletal sites,
P=0.0075 for hip BMD and P=0.0014 for spine BMD. These
data underscore the highly complex architecture of this locus in
association with BMD, in line with our recent study examining this
same locus for the risk of breast cancer across ethnicities [3]. A
similar study of ancestry-shift refinement mapping of this locus
with regards to BMD is warranted in order to pinpoint the
underlying signal.
The marker rs1524058-T, at 7p14 (STARD3NL), associated with
both spine BMD (P=0.00025) and hip BMD (P=0.0020) in the
East-Asians. A recent GWA study in East-Asians identified
rs1721400 at this same locus as associated with BMD of the
radius, tibia and heel [16]. That marker did not associate with
BMD in Europeans [12] whereas rs1524058 associated with BMD
in people of East-Asian ancestry in this study as well as in
Europeans in the previous meta-analysis. Rs1721400 and
rs1524058 are located 75 kb apart and are somewhat correlated
in the HapMap-JPT+CHB dataset (r2 = 0.230, D’ = 0.931),
whereas limited linkage-disequilibrium (LD) is observed for the
CEU data (r2 = 0.015, D’ = 0.194). This suggests that the
rs1524058 is perhaps closer to the underlying signal at this locus
than rs1721400.
At the second chromosome 7 locus, 7q21 (FLJ42280), both
markers associated with both hip BMD and spine BMD. These
markers showed significant heterogeneity between the studies,
explained by the large effect on BMD in the Hong Kong-II
samples.
All five markers at the 8q24 (TNFRSF11B, OPG) locus
associated with spine BMD in the East-Asians, rs6469792-C most
significantly (P=3.461025), and two of the five, rs6469792-C and
rs6993813-C, also associated with hip BMD. Substantial hetero-
geneity was observed for markers at this locus for hip BMD. This
locus was more strongly associated with spine BMD than hip
BMD in previous studies of Europeans, although it was GWS for
both skeletal sites.
The 11q13 (LRP5) rs599083-G marker associated with both
spine BMD (P=0.0014) and hip BMD (P=0.0033) in the East-
Asians. Many studies have previously shown association between
markers in the LRP5 (low density lipoprotein receptor-related
Table 3. Association of European loci in East-Asian samples; hip BMD.
Korea (n =1,396)
HongKong-I
(n = 3,736)
Hong Kong-II
(n =785) (n =5,988)
Locus SNP Allele
Freq.
Europe
Freq.
Asia Effect P value Effect P value Effect P value
Effect
Asia
P value
Asia Phet I
2
1p36 rs7524102 A 0.830 0.794 20.11 0.012 20.11 8.0e-05 20.09 0.0014 20.10 5.5e-08 0.94 0.0
rs6696981 G 0.864 0.803 20.13 0.0070 20.10 0.00016 20.15 9.0e-05 20.12 8.0e-09 0.59 0.0
rs6426749 G 0.830 0.798 20.12 0.0060 20.12 1.5e-05 20.10 0.00090 20.11 4.3e-09 0.86 0.0
rs7543680 G 0.772 0.763 20.08 0.034 20.08 0.0023 20.09 0.012 20.08 2.5e-05 0.97 0.0
1p31 rs2566755 A 0.790 0.773 20.15 0.00075 20.05 0.029 20.06 0.041 20.07 0.00014 0.17 42.7
3p22 rs10490823 G 0.460 0.742 20.07 0.055 20.06 0.0090 20.09 0.0085 20.07 0.00013 0.80 0.0
rs87938 A 0.450 0.639 20.06 0.070 20.04 0.065 20.03 0.14 20.04 0.0095 0.85 0.0
4q22 rs1471403 C 0.660 0.665 0.00 0.50 20.06 0.0060 20.03 0.18 20.05 0.0065 0.63 0.0
5q14 rs1366594 C 0.450 0.584 20.08 0.022 20.05 0.028 20.09 0.00032 20.07 1.3e-05 0.41 0.0
6q25 rs9478223 C 0.104 0.053 20.11 0.10 20.16 0.0031 20.00 0.52 20.09 0.0070 0.21 36.1
rs7751941 A 0.217 0.011 20.29 0.080 20.06 0.28 20.37 0.0043 20.19 0.0075 0.19 39.7
rs2941740 T 0.570 0.884 20.11 0.029 20.07 0.034 20.07 0.046 20.08 0.0011 0.81 0.0
rs1999805 C 0.440 0.754 20.01 0.42 20.08 0.0014 20.02 0.27 20.05 0.0047 0.28 22.1
rs2504063 A 0.400 0.806 20.05 0.15 20.08 0.026 20.04 0.14 20.05 0.011 0.73 0.0
7p14 rs1524058 T 0.400 0.432 20.04 0.14 20.07 0.0015 20.02 0.26 20.05 0.0020 0.37 0.0
7q21 rs4729260 G 0.320 0.137 20.02 0.37 20.03 0.16 20.17 9.0e-06 20.08 0.00038 0.017 75.6
rs7781370 T 0.340 0.132 20.03 0.32 20.04 0.12 20.16 1.9e-05 20.08 0.00025 0.039 69.1
8q24 rs6469792 C 0.529 0.619 0.05 0.89 20.06 0.0085 20.13 8.5e-05 20.05 0.00095 0.0029 82.9
rs6993813 C 0.504 0.655 0.03 0.80 20.04 0.050 20.12 0.00030 20.05 0.0055 0.013 77.1
11p15 rs7117858 A 0.800 0.791 20.08 0.028 20.04 0.10 20.10 0.0018 20.07 0.00033 0.34 6.8
11q13 rs599083 G 0.310 0.264 20.05 0.12 20.03 0.12 20.07 0.0085 20.05 0.0033 0.59 0.0
13q14 rs7992970 A 0.777 0.679 20.06 0.070 20.04 0.050 20.06 0.055 20.05 0.0037 0.86 0.0
rs10507508 A 0.947 0.876 20.15 0.0080 20.04 0.090 20.11 0.011 20.08 0.00075 0.25 28.9
16q24 rs10048146 G 0.190 0.288 20.09 0.011 20.07 0.0055 20.02 0.27 20.05 0.0010 0.26 26.6
17q21 rs1513670 A 0.371 0.595 20.01 0.35 20.05 0.021 20.03 0.16 20.04 0.015 0.75 0.0
The SNPs that were associated with hip BMD in the East-Asian samples in this study are shown. The SNP alleles that associate with lower BMD in Europeans are shown
and their frequency in Europeans and East-Asians. The estimated effect on hip BMD is expressed as standard deviations below the mean. Single-sided P values are
shown for the individual sample sets separately (Korea, Hong Kong-I, Hong Kong-II) and the three sample sets combined. Heterogeneity P values (Phet) and estimates (I
2)
are given.
doi:10.1371/journal.pone.0013217.t003
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protein 5) gene and BMD, both in East-Asians [21–25] and in
Europeans, although these have only reached GWS in Europeans
[11,12,26].
We analysed seven markers at the 13q14 (TNFSF11) locus. The
frequency of five of these markers is markedly different in the East-
Asian populations from that of the Europeans. This locus was the
most strongly associated spine BMD locus in our previous
European studies, represented by T-rs9594738 [9,10] and T-
rs9533090 [12]. Both markers associated nominally with spine
BMD in the East-Asian samples, and rs9594738 associated with
spine BMD (P=0.0010). The frequency of these SNPs is very
different in Asia from that in Europe, 8–9% in East-Asia, versus
50–56% in Europe. Three other markers, rs9594751-T,
rs7992970-A and rs10507508-A, varying in frequency from 6%–
68%–89%, respectively, in the East-Asians, associated with spine
BMD (P=0.00030, 7.561025, 0.00011, respectively). The
rs7992970-A and rs10507508-A markers also associated with hip
BMD (P=0.0037, 0.00075, respectively).
Loci that associated with hip BMD in East-Asian samples
The two loci, 5q14 (MEF2C) and 11p15 (SOX6), showed highly
significant skeletal site specificity in the European meta-analysis
[12], only presenting significant association with hip BMD and not
with spine BMD. The same pattern of skeletal site specificity was
observed in the East-Asian samples, association was observed
between markers at both loci and hip BMD but not for spine
BMD; rs1366594-C at 5q14 and rs7117858-A at 11p15 associated
with hip BMD with P=1.361025 and P=0.00033, respectively.
The marker rs10048146 at 16q24 (FOXL1) was associated with
both hip BMD and spine BMD in the meta-analysis of European
studies [12], but reached GWS level only for spine BMD. In this
study of East-Asians rs10048146-G, however, only associated with
hip BMD, P=0.0010, and although a nominal association was
observed for spine BMD, P= 0.040. The effect on spine BMD is,
however, not significantly different between East-Asians and
Europeans (Table S4).
Rs1513670-A, one of three markers tested at the 17q21 (SOST)
locus, was associated with hip BMD in the East-Asian samples
(P=0.015) but not with spine BMD. Markers at this locus did not
reach GWS in the meta-analysis of European samples but were
significantly associated with total hip BMD and not with spine
BMD in our previous study [10]. In the same study we showed, by
conditional analysis, that there were probably two independent
signals at this locus, one of which was captured by rs1513670.
Effect estimates in East-Asians versus Europeans
We compared the estimated effect of the SNP alleles on BMD in
the East-Asians with the estimated effect of the SNPs in Europeans
(Table S4). Of the fifty markers tested there were fourteen
markers that showed significant differences in effect between East-
Asians and Europeans; twelve for spine BMD and eight for hip
BMD, six common to both sites. Five of the shared markers are
located in the complex 6q25 locus (rs9479055, rs4870044,
rs1038304, rs6929137, rs6900157) and one marker at 13q14
(rs9594759). For hip BMD the 11p11 (rs7932354) and 18q21
(rs3018362) also showed significant difference in effect, whereas for
spine BMD markers at 6p21 (rs3130340), 11p15 (rs7117858),
11p13 (rs16921914) and 17q21 (rs9303521) showed difference in
effect. Other markers at the 6q25 and 13q14 loci did not differ in
effect, leaving six loci signficantly different in their effect on BMD
between East-Asians and Europeans using the set of markers tested
here. The lack of association of the 2p21, 14q32 and 17q21
(HDAC5) loci seems due to lack of power in this study rather than
true differences in the association with BMD between Europeans
and East-Asians, whereas the effect of the markers used in this
study at 6p21, 11p13, 11p11 and 17q21 (CRHR1) are likely to
reflect true differences between the ethnic groups.
Conclusion
Here, we report the influence of sequence variants that were
discovered in European populations on BMD in East-Asians, with
successful identification of fourteen loci associating with BMD.
The effect of BMD association in each of these loci is very similar
to that observed in the European samples; the alleles that
associated with low BMD associated with similar BMD decrease
in SD in both ethnicities. Furthermore, the frequency of the
associated allele is similar in both ethnicities for the majority, but
not all, of the associating markers as is evident for the complex
6q25 and 13q14 loci. We chose to use the FDR test [20] to
determine association because of the a-priori expectation of true
associations. The more conservative Bonferroni correction of the P
values, accounting for all markers tested in this study (P,0.05/50),
would consider ten of the fourteen loci significant (1p36, 1p31,
3p22, 5q14, 7p14, 7q21, 8q24, 11p15, 13q14 and 16q24) and
sixteen loci nominally signficant.
The results for other European loci were inconclusive, although
overall, the effect sizes observed in East-Asians are similar to those
in Europeans and only differ significantly for fourteen markers in
total (twelve for spine and eight for spine, six in common to both
sites). The non-associating loci perhaps reflect ancestry-specific loci
or that the European markers tested here are not capturing the
true association signals due to ethnic LD differences. These data
also indicate that further refinement across different ethnicities,
which was not undertaken in this study, may aid in identifying the
sequence variants that truly affect BMD. Such ancestry-shift
refinement mapping of each of the loci would enable clarification
of the observed signals and determination of ancestry-specificity or
the potential global effect of these loci on BMD.
Materials and Methods
Ethics Statement
All participants provided written informed consent. The study
was approved by Data Protection Commission of Iceland (DPC),
the National Bioethics Committee of Iceland, the AMC Ethics
Review Committee (Seoul), the Clinical Research Ethics Com-
mittee of the Chinese University of Hong Kong local institutional
review boards of University of Hong Kong.
Study Populations
The East-Asian samples used for this study were from Hong
Kong and Korea.
Hong Kong-I: Chinese community elderly Men study and
the Chinese community elderly Women study. Two sets of
samples of different sex, each including 2000 Chinese subjects
living in the community, aged 65 years and above, were recruited
by posting public advertisements at housing estates and
community centers for the elderly in Hong Kong since 2001. To
ensure an even distribution of age, stratified sampling technique
was used where approximately one-thirds of participants were
selected from each of the following age groups: 65–69, 70–74, and
= 75 years old. All subjects were invited to the School of Public
Health of the Chinese University of Hong Kong to have their
peripheral blood samples collected for DNA extraction, and
measurements of their body weight (kg), height (cm), body mass
index (BMI) and bone mineral density (BMD) at various body sites
were also taken. In addition, a questionnaire was administered to
collect information regarding their age, smoking habit, and for
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women subjects specifically, their history of pregnancy and breast
feeding, age of menarche and menopause, and history of estrogen
treatment. The men cohort contributed to the international Mr.
Os study of osteoporosis in men [27]. Baseline BMD
measurements: BMD at the lumbar spine (LS, L1–L4), femoral
neck (FN), total hip (TH), and whole body (WB) were measured by
a dual energy X-ray absorptiometry (DXA) (Hologic QDR-
4500W Densitometer, Hologic Delphi, Hologic Inc, Bedford,
MA). The in vivo precision of DXA was 0.9% at the lumbar spine,
0.7% at the hip, and 1.04% for whole body [27]. BMD normative
reference for the Hong Kong Chinese population was reported
previously [19]. All participants provided informed consent. The
study was approved by the Clinical Research Ethics Committee of
the Chinese University of Hong Kong.
Hong Kong-II: subjects with extreme BMD. The samples
of 785 unrelated women with extreme high or low BMD were
selected from HKSC samples with extreme BMD (n=1,520) and
served as a discovery dataset in [17]. These subjects were selected
from a database (.7,000 Southern Han Chinese volunteers) of the
Osteoporosis Centre of the University of Hong Kong. The low
BMD subjects are defined as an individual having BMD Z-score
#21.28 at either lumbar spine (LS) or femoral neck (FN) (the
lowest 10% of the total populations), while high BMD subjects are
individuals with BMD Z-score $ +1.0 at either sites. Subjects that
were reported to have diseases or environmental factors that may
affect BMD and bone metabolism were excluded. The recruitment
procedure and exclusion criteria have been detailed elsewhere
[28]. BMD (g/cm2) at LS and FN was measured by dual-energy
X-ray absorptiometry (DXA; Hologic QDR 4500 plus, Hologic
Waltham, MA, USA) with standard protocol. The age corrected
and standardized BMD (mean 0, SD 1), termed BMD Z-scores
was generated. Selecting extreme valued individuals for
genotyping is known to inflate effect estimates. In order to
estimate this inflation factor, we simulated two large normal
populations each with standard deviation 1, but one having mean
0 and the other having mean 0.01. We then applied extreme value
thresholding until we observed phenotype variance like that of the
selected samples and used the inflation of the estimated difference
in mean between the two simulated populations to estimate the
BMD effect inflation. For spine BMD the observed inflation in
variance was 2.14 and the effects were estimated to be inflated by a
factor of 2.24. Similarly for hip BMD the observed inflation in
variance was 2.06 and the effects were estimated to be inflated by a
factor of 2.14. We therefore deflated all effect estimates based on
the Hong Kong-II sample by these factors. The in vivo precision of
the machine was 1.2% and 1.5% for LS and FN BMD,
respectively [29]. All participants provided informed consent and
the study protocols were reviewed and approved by local
institutional review boards.
Korea. The study population comprised 1,408 postmen-
opausal women of Korean ethnicity who visited the Osteoporosis
Clinic of Asan Medical Center (AMC, Seoul, Korea) [18].
Menopause was defined as the absence of menstruation for at
least 6 months and confirmed by measurement of serum follicle-
stimulating hormone (FSH). Women who were prematurely
menopausal (,40 years of age) were excluded. Women who had
taken drugs that might affect bone metabolism for .6 months or
within the previous 12 months were also excluded. Subjects were
excluded if they had suffered from any disease that might affect
bone metabolism. Women who had had a stroke or dementia were
also excluded because of concerns related to their limited physical
activity. Women were also excluded if they had osteophyte
formation above the fourth grade of the Nathan classification
and/or severe facet joint osteoarthritis in the lumbar spine using
conventional spine radiographs. Areal BMD (g/cm2) was measured
at the proximal femur and the anterior-posterior lumbar spine (L1
to L4) using dual energy X-ray absorptiometries (DXAs) (Expert
XL, Lunar, Madison, WI, USA; Prodigy Advance, GE, Madison,
WI, USA; and QDR 4500-A, Hologic, Waltham, MA, USA).
Short-term in vivo measurement precision for the Lunar Expert,
Lunar Prodigy andHologic machines, expressed as the coefficient of
variation, were 0.82%, 0.67% and 0.85% for the lumbar spine,
respectively, and 1.12%, 1.25% and 1.20% for the femoral neck,
respectively. Cross-calibration equations among the three systems
were derived in 109 healthy Korean women (55611 years, range
31–75 years), and were calculated as follows; Lumbar BMD
(g/cm2): Lunar Expert = 1.03736Lunar Prodigy 20.0353 Lunar
Expert = 1.12876Hologic 20.0027; Femur neck BMD (g/cm2):
Lunar Expert = 1.05796Lunar Prodigy 20.0275; Lunar Expert
= 1.15566 Hologic +0.0182. All participants provided informed
consent. The study was approved by the AMC Ethics Review
Committee (Seoul).
Genotyping
The Hong Kong-I and the Korean samples were genotyped by
single-SNP Centaurus (Nanogen) assays at deCODE Genetics
[30]. The quality of each Centaurus SNP assay was evaluated by
genotyping each assay in the CEU HapMap samples and
comparing the results with the HapMap data. Assays with a
mismatch rate .1.5% were not used, and a linkage disequilib-
rium (LD) test was used for markers known to be in LD. The
Hong Kong-II samples were genotyped using the Infinium assay
(Illumina, San Diego, USA) with Human610-quad chip. 785
individuals were retained for analysis after exclusion based on
strict quality-control criteria; 1) genotyping call rate less than
95%, 2) autosomal heterozygosity less than 27% or more than
31%, 3) being related or identical to other individuals in the
sample and 4) discordance of observed gender and estimated
gender. All SNPs used in this study satisfied following criteria: 1)
genotyping call rate of 95%, 2) Hardy–Weinberg equilibrium
(HWE) p value above 1.061024, 3) minor allele frequency (MAF)
more than 0.01.
Standardization and Association analysis
For the Korean and Hong Kong –I studies, age and weight
corrected bone mineral density (BMD) was computed for each sex
and population separately to have a mean 0 and standard
deviation 1. For each SNP, a linear regression, using the genotype
as an additive covariate and standardized BMD as the response,
was fitted to test for association. For each SNP, the allele that
associated with lowered BMD in European populations was tested
separately for its association with BMD of the hip and for its
association with BMD of the lumbar spine. Single-sided P values
are reported for the tests for associations in the East-Asians.
An overall Z -score was calculated by using inverse variance
weighted Z -scores. An overall estimate of the effect per allele was
calculated by weighting together the effects in each population by
the population’s effective sample size.
Heterogeneity analysis
Heterogeneity is tested by comparing the null hypothesis of the
effect being the same in all populations to the alternative
hypothesis of each population having a different effect using a
likelihood ratio test. I2 lies between 0% and 100% and describes
the proportion of total variation in study estimates that is due to
heterogeneity [31].
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Supporting Information
Table S1 Markers tested in this study. All SNPs analysed in the
East-Asian samples are shown, their chromosomal position, alleles
and the tested allele. The frequency of the allele that associated
with lowered BMD in Europeans is shown and its effect on spine
BMD and hip BMD along with the respective P values.
Found at: doi:10.1371/journal.pone.0013217.s001 (0.24 MB
DOC)
Table S2 Results for spine BMD for all the SNPs tested in the
East-Asian samples. The effect on spine BMD in the East-Asian
populations of all SNPs tested in this study. The frequency of the
allele that associated with lowered BMD in Europeans is shown
along with its effect on spine BMD. A FDR of 0.05, corresponding
to a P value threshold of 0.021, was used to determine significance
of association.
Found at: doi:10.1371/journal.pone.0013217.s002 (0.16 MB
DOC)
Table S3 Results for hip BMD for all the SNPs tested in the
East-Asian samples. The effect on hip BMD in the East-Asian
populations of all SNPs tested in this study. The frequency of the
allele that associated with lowered BMD in Europeans is shown
along with its effect on hip BMD. A FDR of 0.05, corresponding
to a P value threshold of 0.025, was used to determine significance
of association.
Found at: doi:10.1371/journal.pone.0013217.s003 (0.16 MB
DOC)
Table S4 Difference in effect on BMD between Europeans and
East-Asians. The effect on hip BMD and spine BMD in
populations of European descent and of East-Asian descent of
SNPs tested in this study. The frequency of the allele that
associated with lowered BMD in Europeans is shown for
Europeans and for East-Asians along with its effect on spine
BMD and hip BMD in both ethnicities. The P value comparing
the effect between the two ethnicities is shown. Effects deemed
different using a FDR of 0.05 corresponds to a P value threshold of
0.012 for Spine BMD and 0.008 for Hip BMD.
Found at: doi:10.1371/journal.pone.0013217.s004 (0.13 MB
DOC)
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